ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
2,2,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,Y
4,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,2,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
5,2,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
5,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6,1,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
6,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6,3,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
7,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
9,1,Dry gangrene,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
9,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
10,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
11,1,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
12,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
12,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
12,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
13,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
13,2,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
13,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,4,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
13,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
14,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
14,2,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
14,3,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
15,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
16,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
16,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
17,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
17,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
17,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
17,7,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
17,8,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
17,9,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
17,10,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
17,11,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
17,12,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
17,13,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
17,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
17,15,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
18,1,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
19,1,Administration site extravasation,Administration site reactions NEC,Administration site reactions,Genrl,N
19,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
19,3,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
19,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
20,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
20,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
20,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
21,1,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
21,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
22,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
22,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
22,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
22,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,5,Scrotal oedema,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
22,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
23,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
23,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
23,4,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
24,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
25,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
25,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
26,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
27,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
27,2,Limb amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
28,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
28,2,Limb amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
29,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
29,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
29,4,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,5,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
29,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
29,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
29,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
29,9,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
